Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-254-4 | CAS number: 56-06-4
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: secondary source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: acetone (for challenge)
- Concentration / amount:
- Induction:
Induction Concentration: 5%, 2.5%, 1.0% and 0.5%
Intradermal injection: 2.5%
Topical:100%
Challenge
2.5, 50, 75 and 100 mg moistened with acetone - Route:
- other: epicutaneous, not specified
- Vehicle:
- other: acetone (for challenge)
- Concentration / amount:
- Induction:
Induction Concentration: 5%, 2.5%, 1.0% and 0.5%
Intradermal injection: 2.5%
Topical:100%
Challenge
2.5, 50, 75 and 100 mg moistened with acetone - No. of animals per dose:
- 20 (test group)
10 (control group) - Details on study design:
- For the topical induction phase, the skin was treated with sodium lauryl sulfate
- Challenge controls:
- no
- Positive control substance(s):
- yes
- Remarks:
- α-Hexylcinnamaldehyde
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100mg
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100mg. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
Information is available from the full public report issued by the Australian competent authority (NICNAS); it is therefore assumed to provide reliable information.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
